Literature DB >> 29607792

Nutritional strategies to prevent gastrointestinal toxicity during pelvic radiotherapy.

Linda J Wedlake1.   

Abstract

Radiotherapy-induced damage to non-cancerous gastrointestinal mucosa has effects on secretory and absorptive functions and can interfere with normal gastrointestinal physiology. Nutrient absorption and digestion may be compromised. Dietary manipulation is an attractive option with sound rationale for intervention. The aim of this review was to synthesise published evidence for the use of elemental formulae, low or modified fat diets, fibre, lactose restriction and probiotics, prebiotics and synbiotics to protect the bowel from gastrointestinal side effects during long-course, radical pelvic radiotherapy. Thirty original studies (recruiting n 3197 patients) were identified comprising twenty-four randomised controlled trials, four cohort studies and two comparator trials. Endpoints varied and included symptom scales (Inflammatory Bowel Disease Questionnaire, Common Technology Criteria for Adverse Events, Radiation Therapy Oncology Group) and Bristol Stool Scale. Dietary and supplement interventions were employed with many studies using a combination of interventions. Evidence from RCT was weak for elemental, low or modified fat and low-lactose interventions and modestly positive for the manipulation of fibre during radiotherapy. Evidence for probiotics as prophylactic interventional agents was more promising with a number of trials reporting positive results but strength and strains of interventions vary, as do methodologies and endpoints making it difficult to arrive at firm conclusions with several studies lacking statistical power. This consolidated review concludes that there is insufficient high-grade evidence to recommend nutritional intervention during pelvic radiotherapy. Total replacement of diet with elemental formula could be effective in severe toxicity but this is unproven. Probiotics offer promise but cannot be introduced into clinical practice without rigorous safety analysis, not least in immunocompromised patients.

Entities:  

Keywords:  CFU colony-forming units; IDBQ-B inflammatory bowel disease questionnaire-bowel; LCT long-chain TAG; MCT medium chain TAG; RCT randomised controlled trials; Dietary intervention; Gastrointestinal; Nutrition; Pelvic radiotherapy; Toxicity

Mesh:

Year:  2018        PMID: 29607792     DOI: 10.1017/S0029665118000101

Source DB:  PubMed          Journal:  Proc Nutr Soc        ISSN: 0029-6651            Impact factor:   6.297


  4 in total

1.  Gastrointestinal consequences of cancer treatment: evaluation of 10 years' experience at a tertiary UK centre.

Authors:  Radha Gadhok; Emma Paulon; Chehkuan Tai; Tomisin Olushola; John Barragry; Farooq Rahman; Simona Di Caro; Shameer Mehta
Journal:  Frontline Gastroenterol       Date:  2020-08-11

2.  Progressive Skeletal Muscle Loss After Surgery and Adjuvant Radiotherapy Impact Survival Outcomes in Patients With Early Stage Cervical Cancer.

Authors:  Jie Lee; Jhen-Bin Lin; Tze-Chien Chen; Ya-Ting Jan; Fang-Ju Sun; Yu-Jen Chen; Meng-Hao Wu
Journal:  Front Nutr       Date:  2022-01-20

3.  A Study of Self-Care Practice in Routine Radiotherapy Care: Identifying Differences Between Practitioners and Non-Practitioners in Sociodemographic, Clinical, Functional, and Quality-of-Life-Related Characteristics.

Authors:  Kerstin Stake-Nilsson; Silje Gustafsson; Kristina Tödt; Per Fransson; Anna Efverman
Journal:  Integr Cancer Ther       Date:  2022 Jan-Dec       Impact factor: 3.077

4.  Bile Acid Malabsorption as a Consequence of Cancer Treatment: Prevalence and Management in the National Leading Centre.

Authors:  Caroline Gee; Catherine Fleuret; Ana Wilson; Daniel Levine; Ramy Elhusseiny; Ann Muls; David Cunningham; Darina Kohoutova
Journal:  Cancers (Basel)       Date:  2021-12-10       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.